Security key
29664W105
Esperion Therapeutics, Inc. - Common Stock (ESPR)
CUSIP: 29664W105
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 125,253,343
- Total 13F value
- $335,669,495
- Share change
- +53,612,768
- Put/Call ratio
- 55%
- SEC-reported price per share
- $2.68
- Number of holders
- 147
- Value change
- +$141,351,114
- Number of buys
- 85
- Number of sells
- 47
- Shares outstanding
- 257,974,488
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
147
Top holders
10
Broader feeds
Ownership snapshot
Top reported holders of ESPR - Esperion Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
147
Shares
125,253,343
Rows available
147
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
147
Q1 2024 holders
147
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|